generic medications
Eli Lilly’s Market Share Declines as Novo Nordisk Maintains Position
Eli Lilly’s market share is declining in India due to generic weight-loss drugs, while Novo Nordisk maintains a stable position amidst competition.
Pharmaceutical Stocks Surge as Ozempic Ingredient Patent Expires
Pharmaceutical stocks have surged up to 4% as Ozempic’s key ingredient patent expires, paving the way for generics and transforming obesity treatment.